Replies to post #218409 on Elite Pharmaceuticals Inc (ELTP)

[Aqua]

For the elementary school Aqua attended, unsatisfactory performance is a "U".

U = Unsatisfactory

As for Hakim, he is far from being a failure as he facilitated the growth in our diversified drug pipeline and achieved steady revenue growth. It would not be fair to judge him on achieving FDA-approval for SequestOX alone. That would be premature considering that he and his team would be in discussions about the deficiencies with the FDA. The CRL might be the best thing to ever happen to Elite as early detection of deficiencies in SequestOX would spare Elite the expenditure of precious time and financial resources.

Cheers!